PRODUCT DEVELOPMENT PROTOCOL REENGINEERING PROPOSAL SUGGESTS "REAL-TIME" REVIEWS OF CHANGES DURING STUDIES; PMA REENGINEERING TEAM TO BE FORMED
This article was originally published in The Gray Sheet
Executive Summary
FDA expects "real-time" reviews during the product development protocol process will help eliminate obstacles that prevented effective use of the PDP approach in the past.